NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

抗生劑抗性的全球市場:新興治療藥的認證及銷售促進市場擴大

Global Market Study on Antibiotic Resistance: Approval & Launch of Novel Therapeutics Aiding Market Expansion

出版商 Persistence Market Research 商品編碼 1004409
出版日期 內容資訊 英文 272 Pages
商品交期: 2-3個工作天內
價格
抗生劑抗性的全球市場:新興治療藥的認證及銷售促進市場擴大 Global Market Study on Antibiotic Resistance: Approval & Launch of Novel Therapeutics Aiding Market Expansion
出版日期: 2021年02月10日內容資訊: 英文 272 Pages
簡介

本報告提供全球抗生劑抗性市場相關調查分析,以機會及目前的市場情勢為焦點,提供影響市場的支援部門相關詳細的分析和更新。

調查提供有關市場上的促進因素,阻礙因素,趨勢,機會等,主要的市場動態的詳細考察。主要目的,是提供對2021年∼2031年的預測期間內,市場如何作用相關的專門性資訊。

目錄
Product Code: PMRREP27895

Antibiotic Resistance Market - Scope of Report

A latest publication by Persistence Market Research on the global antibiotic resistance market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the antibiotic resistance market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the antibiotic resistance market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers know the demand for antibiotic resistance products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the antibiotic resistance space, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the antibiotic resistance market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibiotic resistance market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the antibiotic resistance industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the antibiotic resistance market offers information divided into six important segments - drug class, pathogen, disease, mechanism of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Drug Class

Beta Lactam Antibiotics

Cephalosporin

Quinolones Antibiotics

Macrolide Antibiotics

Tetracycline

Oxazolidinones

Others

Pathogen

Staphylococcus aureus

Streptococcus pneumonia

Neisseria gonorrhoeae

Enterococcus faecium

Escherichia coli

Klebsiella Pneumonia

Shigella

Clostridium difficile

Others

Disease

Community Acquired Bacterial Pneumonia (CABP)

Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)

Complicated Urinary Tract Infections (CUTI)

Complicated Intra-Abdominal Infections (CIAI)

Blood Stream Infections (BSI)

Abdominal Infection and Diarrhoea (Clostridium difficile infections (CDI) & Shigella)

Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Drug Resistant Gonorrhoeae

Mechanism of Action

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors

DNA Synthesis Inhibitors

RNA Synthesis Inhibitors

Others

Distribution Channel

Hospitals Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

MEA

Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for antibiotic resistance?

Which parameters will bring a change in the demand for antibiotic resistance products during the forecast period?

How will changing trends impact the market?

How will the COVID-19 pandemic impact market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the winning strategies of stakeholders in the antibiotic resistance market to upscale their position in this landscape?

What are the restraints that investors need to be aware of and might tackle while investing in the market?

How can businesses in the antibiotic resistance market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the antibiotic resistance market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the antibiotic resistance market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the antibiotic resistance market more accurate and reliable.

List of Tables

  • Table 01: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 01: Global Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 03: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 04: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 05: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 06: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 07: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Region
  • Table 08: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 09: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 10: North America Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 11: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 12: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 13: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 14: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 15: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 16: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 17: Latin America Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 18: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 19: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 20: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 21: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 22: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 23: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 24: Europe Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 25: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 26: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 27: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 28: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 29: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 30: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 31: South Asia Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 32: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 33: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 34: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 35: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 36: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 37: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 38: East Asia Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 39: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 40: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 41: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 42: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 43: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 44: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 45: Oceania Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 46: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 47: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 48: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 49: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 50: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 51: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 52: MEA Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 53: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 54: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 55: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 56: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel

List of Figures

  • Figure 01: Global Antibiotic Resistance Market Volume (Mn Units) Analysis 2016-2020
  • Figure 02: Global Antibiotic Resistance Market Volume (Mn Units) Analysis and Forecast 2021-2031 
  • Figure 03: Beta Lactam Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 04: Cephalosporin Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 05: Quinolones Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 06: Macrolide Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 07: Tetracycline Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 08: Oxazolidinones plate Pricing Analysis (US$) for Per Unit, By Others, 2020
  • Figure 09: Others Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 10: Global Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 11: Global Antibiotic Resistance Market Value Analysis and Forecast 2021 - 2031 (US$ Mn)
  • Figure 12: Global Antibiotic Resistance Market Absolute $ Opportunity (US$ Mn), 2020-2031
  • Figure 13: Global Antibiotic Resistance Market Share Analysis (%) By Drug Class, 2021 & 2031
  • Figure 14: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Drug Class, 2021-2031
  • Figure 15: Global Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 16: Global Antibiotic Resistance Market Share Analysis (%) By Pathogen 2021 & 2031
  • Figure 17: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Pathogen, 2021-2031
  • Figure 18: Global Antibiotic Resistance Market Attractiveness Analysis, By Pathogen, 2021- 2031
  • Figure 19: Global Antibiotic Resistance Market Share Analysis (%) By Disease, 2021 & 2031
  • Figure 20: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Disease, 2021- 2031
  • Figure 21: Global Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 22: Global Antibiotic Resistance Market Share Analysis (%) By Mechanism of action, 2021 & 2031
  • Figure 23: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Mechanism of action, 2021-2031
  • Figure 24: Global Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 25: Global Antibiotic Resistance Market Share Analysis (%) By Distribution Channel, 2021 & 2031
  • Figure 26: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Distribution Channel, 2021-2031
  • Figure 27: Global Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 28: Global Antibiotic Resistance Market Share Analysis (%) By Region, 2021 & 2031
  • Figure 29: Global Antibiotic Resistance Market Y-o-Y Growth (%) By Region, 2021-2031
  • Figure 30: Global Antibiotic Resistance Market Attractiveness Analysis, By Region, 2021- 2031
  • Figure 31: North America Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 32: North America Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 33: North America Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 34: North America Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 35: North America Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 36: North America Antibiotic Resistance Market Value Share, By Distribution Channel (E)
  • Figure 37: North America Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 38: North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 39: North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 40: North America Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 41: North America Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 42: North America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 43: North America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 44: North America Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 45: North America Antibiotic Resistance Market Attractiveness Analysis, By Country, 2021- 2031
  • Figure 46: Latin America Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 47: Latin America Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 48: Latin America Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 49: Latin America Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 50: Latin America Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 51: Latin America Antibiotic Resistance Market Value Share, By Distribution Channel (E)
  • Figure 52: Latin America Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 53: Latin America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 54: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 55: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 56: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 57: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 58: Latin America Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 59: Latin America Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 60: Europe Antibiotic Resistance Market Value Share, By Country
  • Figure 61: Europe Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 62: Europe Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 63: Europe Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 64: Europe Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 65: Europe Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 66: Europe Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 67: Europe Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 68: Europe Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 69: Europe Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 70: Europe Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 71: Europe Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 72: Europe Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 73: South Asia Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 74: South Asia Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 75: South Asia Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 76: South Asia Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 77: South Asia Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 78: South Asia Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 79: South Asia Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 80: South Asia Antibiotic Resistance Market Value (US$ Mn) 2016-2020
  • Figure 81: South Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 82: South Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 83: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 84: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 85: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 86: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 87: South Asia Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 88: East Asia Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 89: East Asia Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 90: East Asia Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 91: East Asia Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 92: East Asia Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 93: East Asia Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 94: East Asia Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 95: East Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 96: East Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 97: East Asia Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 98: East Asia Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 99: East Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 100: East Asia Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031
  • Figure 101: Oceania Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 102: Oceania Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 103: Oceania Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 104: Oceania Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 105: Oceania Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 106: Oceania Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 107: Oceania Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 108: Oceania Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 109: Oceania Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 110: Oceania Antibiotic Resistance Market Attractiveness Analysis By Drug Class, 2021- 2031
  • Figure 111: Oceania Antibiotic Resistance Market Attractiveness Analysis By Disease, 2021- 2031
  • Figure 112: Oceania Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 113: Oceania Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 114: Oceania Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031
  • Figure 115: MEA Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 116: MEA Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 117: MEA Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 118: MEA Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 119: MEA Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 120: MEA Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 130: MEA Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 131: MEA Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 132: MEA Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 133: MEA Antibiotic Resistance Market Attractiveness Analysis By Drug Class, 2021- 2031
  • Figure 134: MEA Antibiotic Resistance Market Attractiveness Analysis By Disease, 2021- 2031
  • Figure 135: MEA Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 136: MEA Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 137: MEA Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031
  • Figure 138: US. Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 139: US. Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 140: US. Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 141: US. Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 142: US. Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 143: Canada Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 144: Canada Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 145: Canada Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 146: Canada Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 147: Canada Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 148: Brazil Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 149: Brazil Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 150: Brazil Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 151: Brazil Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 152: Brazil Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 153: Mexico Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 154: Mexico Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 155: Mexico Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 156: Mexico Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 157: Mexico Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 158: Argentina Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 159: Argentina Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 160: Argentina Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 161: Argentina Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 162: Argentina Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 163: Germany Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 164: Germany Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 165: Germany Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 166: Germany Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 167: Germany Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 168: Italy Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 169: Italy Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 170: Italy Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 171: Italy Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 172: Italy Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 173: France Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 174: France Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 175: France Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 176: France Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 177: France Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 178: U.K. Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 179: U.K. Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 180: U.K. Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 181: U.K. Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 182: U.K. Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 183: Spain Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 184: Spain Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 185: Spain Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 186: Spain Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 187: Spain Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 188: BENELUX Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 189: BENELUX Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 190: BENELUX Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 191: BENELUX Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 192: BENELUX Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 193: Russia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 194: Russia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 195: Russia Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 196: Russia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 197: Russia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 198: India Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 199: India Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 200: India Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 201: India Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 202: India Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 203: Thailand Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 204: Thailand Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 205: Thailand Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 206: Thailand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 207: Thailand Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 208: Malaysia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 209: Malaysia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 210: Malaysia Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 211: Malaysia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 212: Malaysia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 213: China Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 214: China Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 215: China Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 216: China Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 217: China Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 218: Japan Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 219: Japan Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 220: Japan Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 221; Japan Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 222: Japan Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 223: Australia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 224: Australia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 225: Australia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 226: Australia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 227: Australia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 228: New Zealand Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 229: New Zealand Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 230: New Zealand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 231: New Zealand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 232: New Zealand Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 233: GCC Countries Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 234: GCC Countries Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 235: GCC Countries Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 236: GCC Countries Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 237: GCC Countries Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 238: Turkey Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 239: Turkey Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 240: Turkey Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 241: Turkey Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 242: Turkey Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 243: South Africa Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 244: South Africa Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 245: South Africa Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 246: South Africa Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 247: South Africa Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)